Pharmaceutical Gelatin Market, By Source (Porcine, Bovine Skin, Bovine Bone, and Fish and Poultry), By Type (Type A and Type B), By Function (Stabilizing, Thickening, and Gelling), By Application (Food, Pharmaceuticals, and Healthcare), and By Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) – Market Trends, Analysis, and Forecast Till 2029

Gelatin is the leading excipient in the pharmaceutical industry and is used in wide variety of applications ranging from the production of hard and soft drug capsules to film formation and tablet binding. Pharmaceutical gelatin is also used in the food, cosmetics, and in dietary supplements as a flavour enhancer. It is a source of collagen and the amino acids L-proline, L-hydroxyproline and glycine. US Food and Drug Administration provide guidance on the use of gelatin in pharmaceutical products. It is colorless, harmless and absorbable, translucent and a delicate element that has a high molecular weight. It is derived from skin, white connective tissues, and bones of animals by partial hydrolysis of collagen. The growing demand for functional and convenience food & beverage products, increasing application in the pharmaceutical industry, and the rising demand for clean label products drive the demand for gelatin. 

 Impact of COVID-19 pandemic on market

The rising prevalence of COVID-19 has driven the demand for pharmaceutical industry across the globe. However, the quarantine and lockdown measures effects in various regions have resulted in transport and logistics issues, causing difficulty in supply chain of raw material for pharmaceutical gelatin. This has affected the supply of pharmaceutical gelatin in some regions, resulting in a supply-demand gap. Countries with prolonged periods of lockdown such as India and China have been affected more severely than others, such as, US and countries of the European Union. This report will quantify the impact of this pandemic on the Pharmaceutical Gelatin Market.

The major factor that drive the growth are increase in nutraceuticals and pharmaceuticals industries, increasing awareness about the consumption of nutrition rich, and growing geriatric population that aims to manufacture drugs utilizing gelatin. Powdered and sugar form of gelatin is used in the preparation of artisanal pastry, desserts, and various other specialty food products. Gelatin in hydrolyzed form is used to protein fortify dietary foods. The unique functional capabilities of gelatin such as gelling, adhesion, coating, binding, and film-building makes it highly advantageous for use in the pharmaceutical industry. Gelatin coating on hard capsules, softgel capsules, and tablets not only masks the odor of medicines but also facilitates ease in swallowing. Moreover, the properties of gelatin provide protection against environmental changes associated with oxygen or moisture, thereby increasing the shelf-life of these products. These superior functional properties of gelatin are a driver for the pharmaceutical gelatin market.

However, the increasing demand for plant-based pharmaceutical products manufacturers are expected to restrain the growth of pharmaceutical gelatin during the forecast period. Rising trend in veganism across the world, capsule manufacturers offering non-gelatin capsules or vegetarian capsules manufactured from purely plant-derived materials to meet the demands of consumers.

The global pharmaceutical gelatin market is segmented based on the source, type, function, application, and region.

Base on the source, the global market is segmented into porcine, bovine skin, bovine bone, and fish and poultry. Mostly total world’s gelatin is sourced from porcine, followed by bovine skin, bones, and other sources such as fish skin. Pigskin is rich in collagen proteins, which are considered to be more stable in comparison with gelatin from other sources. Further, the gelatin sourced from fish and poultry is among the trendy ones and are mostly processed to satisfy the demand of specific religious consumer groups.

On the basis of type, the global pharmaceutical market is divided into type A and type B. The type A gelatin is used in confectionary as food grade gelatin. Type B used in dairy products. The increasing preference for bovine bone for the manufacture of pharmaceutical gelatin and cultural acceptability of bovine source is driving the growth of the Type B segment.

Based on function, the pharmaceutical gelatin market is segmented into stabilizing, thickening, and gelling. The thickening segment is estimated to grow at the highest growth due to its increasing scope of application in medicinal syrups, elixirs, and other liquid dosage forms. Therefore, gelatin is used to increase the viscosity of the dosage form without altering its other properties. The utility of gelatin as a thickening agent in antibiotic creams and lotions are also driving the growth of this segment. The pharmaceutical gelatin application is categorized into food, pharmaceuticals and health care. Gelatin is a highly rich protein source to be incorporated into functional & nutritional food & beverage products. The rising demand for nutritional food & beverages has been stimulating the demand for gelatin.

Based on the region, market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The pharmaceutical gelatin market in the Asia Pacific region is expected to grow at the highest rate during 2019-2029. In this region, there is vast availability of porcine and bovine source of raw material, low cost of labor and capital investment, due to which major market players are investing in this region. These factors are driving the growth of the global pharmaceutical gelatin market in Asia Pacific region.

Detail Segmentation:

Attribute	Details
The base year for estimation	2019
Forecast Period	2019 - 2029
Market Representation	Revenue in USD Billion & CAGR from 2019-2029
Market Segmentation	By Source – Porcine, Bovine Skin, Bovine Bone, and Fish and Poultry By Type – Type A and Type B By Function – Stabilizing, Thickening, and Gelling By Application – Food, Pharmaceuticals and Healthcare By Region - North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Regional Scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report Coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered in the report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029.  For the purpose of this study, has segmented the global pharmaceutical gelatin market report based on source, type, function, application, and region.

Global Pharmaceutical Gelatin Market, By Source:

• o Porcine
• o Bovine Skin
• o Bovine Bone
• o Fish
• o Poultry

Global Pharmaceutical Gelatin Market, By Type:

• o Type A
• o Type B

Global Pharmaceutical Gelatin Market, By Function:

• o Stabilizing
• o Thickening
• o Gelling

Global Pharmaceutical Gelatin Market, By Application:

• o Food
• o Pharmaceuticals
• o Healthcare

Global Pharmaceutical Gelatin market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The prominent players in the global pharmaceutical gelatin market include Darling Ingredients Inc., Nitta Gelatin Inc, Tessenderlo Group, Gelita AG, Weishardt, Trobas Gelatine B.V., Lapi Gelatine S.p.A, Italgelatine S.p.A, Xiamen Gelken Gelatin Co. Ltd., and Gelco International. Prominent key players in the market are undertaking various strategies such as new product launches required for clinical applications. For instance, in July 2020, Darling Ingredients Inc. announced that its Rousselot business, the global leader of collagen-based solutions, has successfully introduced X-Pure GelMA at Bio Digital 2020. The first Good Manufacturing Practice (GMP)-ready range of gelatin methacryloyl (GelMA) biomaterials suitable for preclinical and clinical applications.

• Darling Ingredients Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
• Nitta Gelatin Inc
• Tessenderlo Group
• Gelita AG
• Weishardt
• Trobas Gelatine B.V.
• Lapi Gelatine S.p.A
• Italgelatine S.p.A
• Xiamen Gelken Gelatin Co. Ltd.
• Gelco International.